Laddar...
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial
OBJECTIVES: Fixed-dose rate gemcitabine plus docetaxel is active as second-line therapy for metastatic uterine leiomyosarcoma. We sought to determine the activity of this regimen as first-line treatment. METHODS: Eligible women with advanced uterine leiomyosarcoma were treated with gemcitabine 900 m...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2008
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2504727/ https://ncbi.nlm.nih.gov/pubmed/18534250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2008.03.010 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|